.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKesson
Harvard Business School
McKinsey
Fish and Richardson
Julphar
US Army
Dow
US Department of Justice
Colorcon
Argus Health

Generated: December 12, 2017

DrugPatentWatch Database Preview

Griseofulvin, microsize - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for griseofulvin, microsize and what is the scope of griseofulvin, microsize freedom to operate?

Griseofulvin, microsize
is the generic ingredient in two branded drugs marketed by Valeant Luxembourg, Actavis Mid Atlantic, Chartwell Rx, Cipla Ltd, Vintage Pharms, Sandoz Inc, and Sigmapharm Labs Llc, and is included in eight NDAs. Additional information is available in the individual branded drug profile pages.

There is one drug master file entry for griseofulvin, microsize. Seven suppliers are listed for this compound.

Pharmacology for griseofulvin, microsize

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Valeant LuxembourgGRIFULVIN Vgriseofulvin, microsizeTABLET;ORAL062279-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Actavis Mid AtlanticGRISEOFULVINgriseofulvin, microsizeSUSPENSION;ORAL065394-001Jul 6, 2007ABRXNoYes► Subscribe► Subscribe► Subscribe► Subscribe
Sigmapharm Labs LlcGRISEOFULVINgriseofulvin, microsizeTABLET;ORAL202482-001Oct 22, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Chartwell RxGRISEOFULVINgriseofulvin, microsizeSUSPENSION;ORAL065200-001Mar 2, 2005ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Valeant LuxembourgGRIFULVIN Vgriseofulvin, microsizeSUSPENSION;ORAL062483-001Jan 26, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Cipla LtdGRISEOFULVINgriseofulvin, microsizeSUSPENSION;ORAL065354-001Sep 10, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Sandoz IncGRISEOFULVINgriseofulvin, microsizeTABLET;ORAL091592-002Aug 7, 2013ABRXNoYes► Subscribe► Subscribe► Subscribe► Subscribe
Sandoz IncGRISEOFULVINgriseofulvin, microsizeTABLET;ORAL091592-001Aug 7, 2013RXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Vintage PharmsGRISEOFULVINgriseofulvin, microsizeSUSPENSION;ORAL065438-001Oct 8, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Army
Teva
Chinese Patent Office
Merck
Cerilliant
Boehringer Ingelheim
Citi
Deloitte
Dow
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot